Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Berthelsen DB, Horgan B, Simon L, Ioannidis JPA, Goel N, Tugwell P, Balay-Dustrude E, Bartlett SJ, Bingham CO, Boers M, Bouillot C, Böhm P, Choy E, Cowern M, Dagsvik K, Djurtoft C, Furst DE, Haugegaard T, Hazlewood GS, Hoens AM, Jørgensen TS, Kelly SE, Kruzikas D, Musaus J, Richards P, Shea BJ, Strand V, Thomas M, Torralba K, Voshaar M, Weinbrecht-Mischkewitz M, Woodworth TG, Wright G, Flurey C, Christensen R, OMERACT Safety Working Group

Open source

DOI
10.1016/j.semarthrit.2026.153026
Published
2026 Aug
Container
Seminars in arthritis and rheumatism
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.semarthrit.2026.153026,
  title = {Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.},
  author = {Berthelsen DB and Horgan B and Simon L and Ioannidis JPA and Goel N and Tugwell P and Balay-Dustrude E and Bartlett SJ and Bingham CO and Boers M and Bouillot C and Böhm P and Choy E and Cowern M and Dagsvik K and Djurtoft C and Furst DE and Haugegaard T and Hazlewood GS and Hoens AM and Jørgensen TS and Kelly SE and Kruzikas D and Musaus J and Richards P and Shea BJ and Strand V and Thomas M and Torralba K and Voshaar M and Weinbrecht-Mischkewitz M and Woodworth TG and Wright G and Flurey C and Christensen R and OMERACT Safety Working Group},
  year = {2026},
  journal = {Seminars in arthritis and rheumatism},
  doi = {10.1016/j.semarthrit.2026.153026},
  url = {https://doi.org/10.1016/j.semarthrit.2026.153026}
}

RIS

TY  - JOUR
TI  - Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.
AU  - Berthelsen DB
AU  - Horgan B
AU  - Simon L
AU  - Ioannidis JPA
AU  - Goel N
AU  - Tugwell P
AU  - Balay-Dustrude E
AU  - Bartlett SJ
AU  - Bingham CO
AU  - Boers M
AU  - Bouillot C
AU  - Böhm P
AU  - Choy E
AU  - Cowern M
AU  - Dagsvik K
AU  - Djurtoft C
AU  - Furst DE
AU  - Haugegaard T
AU  - Hazlewood GS
AU  - Hoens AM
AU  - Jørgensen TS
AU  - Kelly SE
AU  - Kruzikas D
AU  - Musaus J
AU  - Richards P
AU  - Shea BJ
AU  - Strand V
AU  - Thomas M
AU  - Torralba K
AU  - Voshaar M
AU  - Weinbrecht-Mischkewitz M
AU  - Woodworth TG
AU  - Wright G
AU  - Flurey C
AU  - Christensen R
AU  - OMERACT Safety Working Group
PY  - 2026
JO  - Seminars in arthritis and rheumatism
DO  - 10.1016/j.semarthrit.2026.153026
UR  - https://doi.org/10.1016/j.semarthrit.2026.153026
ER  -

APA

DB, B., B, H., L, S., JPA, I., N, G., P, T., E, B., SJ, B., CO, B., M, B., C, B., P, B., E, C., M, C., K, D., C, D., DE, F., T, H., GS, H., AM, H., TS, J., SE, K., D, K., J, M., P, R., BJ, S., V, S., M, T., K, T., M, V., M, W., TG, W., G, W., C, F., R, C., & Group, O. S. W. (2026). Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.. Seminars in arthritis and rheumatism. https://doi.org/10.1016/j.semarthrit.2026.153026

Source records